Skip to main content

letter

. 1995 Aug 12;311(7002):455–456. doi: 10.1136/bmj.311.7002.455c

Polymyalgia rheumatica and giant cell arteritis. Consider prophylaxis for steroid induced osteoporosis.

S Jamieson, F Thomson

PMCID: PMC2550520 PMID: 7640615

456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hall G. M., Daniels M., Doyle D. V., Spector T. D. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum. 1994 Oct;37(10):1499–1505. doi: 10.1002/art.1780371014. [DOI] [PubMed] [Google Scholar]
Joseph J. C. Corticosteroid-induced osteoporosis. Am J Hosp Pharm. 1994 Jan 15;51(2):188–230. [PubMed] [Google Scholar]
Lukert B. P., Johnson B. E., Robinson R. G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res. 1992 Sep;7(9):1063–1069. doi: 10.1002/jbmr.5650070909. [DOI] [PubMed] [Google Scholar]
Pountain G., Hazleman B. ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis. BMJ. 1995 Apr 22;310(6986):1057–1059. doi: 10.1136/bmj.310.6986.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
Spector T. D., Sambrook P. N. Steroid osteoporosis. BMJ. 1993 Aug 28;307(6903):519–520. doi: 10.1136/bmj.307.6903.519. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES